Country-level gender inequality is associated with structural differences in the brains of women and men.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
16 05 2023
Historique:
medline: 10 5 2023
pubmed: 8 5 2023
entrez: 8 5 2023
Statut: ppublish

Résumé

Gender inequality across the world has been associated with a higher risk to mental health problems and lower academic achievement in women compared to men. We also know that the brain is shaped by nurturing and adverse socio-environmental experiences. Therefore, unequal exposure to harsher conditions for women compared to men in gender-unequal countries might be reflected in differences in their brain structure, and this could be the neural mechanism partly explaining women's worse outcomes in gender-unequal countries. We examined this through a random-effects meta-analysis on cortical thickness and surface area differences between adult healthy men and women, including a meta-regression in which country-level gender inequality acted as an explanatory variable for the observed differences. A total of 139 samples from 29 different countries, totaling 7,876 MRI scans, were included. Thickness of the right hemisphere, and particularly the right caudal anterior cingulate, right medial orbitofrontal, and left lateral occipital cortex, presented no differences or even thicker regional cortices in women compared to men in gender-equal countries, reversing to thinner cortices in countries with greater gender inequality. These results point to the potentially hazardous effect of gender inequality on women's brains and provide initial evidence for neuroscience-informed policies for gender equality.

Identifiants

pubmed: 37155867
doi: 10.1073/pnas.2218782120
pmc: PMC10193926
doi:

Types de publication

Meta-Analysis Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2218782120

Commentaires et corrections

Type : CommentIn

Références

Prog Brain Res. 2010;186:13-28
pubmed: 21094883
Mol Psychiatry. 2017 Jun;22(6):900-909
pubmed: 27137745
Mol Psychiatry. 2021 Aug;26(8):4331-4343
pubmed: 33288872
Nature. 2022 Apr;604(7906):525-533
pubmed: 35388223
Ann N Y Acad Sci. 2010 Sep;1204 Suppl:E38-59
pubmed: 20840167
Singapore Med J. 2007 May;48(5):385-91
pubmed: 17453094
Nat Rev Neurosci. 2009 Jun;10(6):434-45
pubmed: 19401723
JAMA Psychiatry. 2018 Sep 1;75(9):918-928
pubmed: 29971329
Neuron. 2013 Dec 18;80(6):1359-67
pubmed: 24316296
Eur Neuropsychopharmacol. 2017 May;27(5):515-525
pubmed: 28279623
Lancet Psychiatry. 2020 Jun;7(6):471-472
pubmed: 32445675
Soc Cogn Affect Neurosci. 2015 Apr;10(4):569-76
pubmed: 24948156
Transl Psychiatry. 2018 May 18;8(1):98
pubmed: 29777100
Nat Neurosci. 2021 Sep;24(9):1216-1224
pubmed: 34294918
Nat Rev Neurosci. 2018 Jul;19(7):428-438
pubmed: 29867123
Lancet Public Health. 2017 Aug;2(8):e356-e366
pubmed: 29253477
Neurosci Biobehav Rev. 2021 Jun;125:667-697
pubmed: 33621637
J Interpers Violence. 2004 Jun;19(6):655-75
pubmed: 15140317
Hum Brain Mapp. 2020 Dec 15;41(18):5164-5175
pubmed: 32845057
Neuroimage. 2010 Nov 15;53(3):1093-102
pubmed: 20156572
Biol Psychiatry. 2021 Aug 1;90(3):182-193
pubmed: 33952400
Brain Imaging Behav. 2014 Jun;8(2):153-82
pubmed: 24399358
J Cogn Neurosci. 2021 May 1;33(6):1197-1209
pubmed: 34428792
J Am Acad Child Adolesc Psychiatry. 2022 Jun;61(6):809-819
pubmed: 34481917
Nat Neurosci. 2015 May;18(5):773-8
pubmed: 25821911
Am J Psychiatry. 2020 Sep 1;177(9):834-843
pubmed: 32539527
Lancet. 2020 Aug 22;396(10250):565-582
pubmed: 32828189
Hum Brain Mapp. 2010 Dec;31(12):1967-82
pubmed: 21086550
Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):E7680-E7689
pubmed: 30061413
Science. 2008 May 30;320(5880):1164-5
pubmed: 18511674
Neuroimage. 2010 Nov 15;53(3):1135-46
pubmed: 20006715
Nat Rev Neurosci. 2006 Sep;7(9):697-709
pubmed: 16924259
Nat Rev Neurosci. 2021 Jun;22(6):372-384
pubmed: 33911229

Auteurs

André Zugman (A)

Section on Development and Affective Neuroscience (SDAN), Emotion and Development Branch (E & D), National Institute of Mental Health, National Institutes of Health, Bethesda MD 20894.

Luz María Alliende (LM)

Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8330077, Chile.
Department of Psychology, Northwestern University, Evanston, IL 60208.

Vicente Medel (V)

Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago 7941169, Chile.

Richard A I Bethlehem (RAI)

Autism Research Centre, Department of Psychiatry, University of Cambridge, Cambridge CB2 8AH, United Kingdom.
Department of Psychology, University of Cambridge, Cambridge CB2 3EB, United Kingdom.

Jakob Seidlitz (J)

Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104.
Department of Child and Adolescent Psychiatry and Behavioral Science, The Children's Hospital of Philadelphia, Philadelphia, PA 19104.
Penn-Children's Hospital of Philadelphia Lifespan Brain Institute, University of Pennsylvania, Philadelphia, PA 19104.

Grace Ringlein (G)

Section on Development and Affective Neuroscience (SDAN), Emotion and Development Branch (E & D), National Institute of Mental Health, National Institutes of Health, Bethesda MD 20894.

Celso Arango (C)

Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Centro de Investigación Biomédica en Red Salud Mental (CIBERSAM), School of Medicine, Universidad Complutense, Madrid 28009, Spain.

Aurina Arnatkevičiūtė (A)

The Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, VIC 3168, Australia.
Monash Biomedical Imaging, Monash University, Melbourne, VIC 3168, Australia.

Laila Asmal (L)

Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7602, South Africa.

Mark Bellgrove (M)

The Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, VIC 3168, Australia.

Vivek Benegal (V)

Centre for Addiction Medicine, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka 560029, India.

Miquel Bernardo (M)

Barcelona Clinic Schizophrenia Unit, Hospital Clínic de Barcelona, Departament de Medicina, Institut de Neurociències (UBNeuro), Universitat de Barcelona (UB), Institut d'Investigacions Biomèdiques, August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Barcelona 08036, Spain.

Pablo Billeke (P)

Laboratorio de Neurociencia Social y Neuromodulación, Centro de Investigación en Complejidad Social (neuroCICS), Facultad de Gobierno, Universidad del Desarrollo, Santiago 7610658, Chile.

Jorge Bosch-Bayard (J)

McGill Centre for Integrative Neuroscience, Ludmer Centre for Neuroinformatics and Mental Health, Montreal Neurological Institute, Montreal, QC H3A 2B4, Canada.
McGill University, Montreal, QC H3A 2B4, Canada.

Rodrigo Bressan (R)

Interdisciplinary Laboratory in Clinical Neuroscience (LiNC), Department of Psychiatry, Federal University of São Paulo, São Paulo 04039-032, Brazil.

Geraldo F Busatto (GF)

Departamento e Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-903, Brazil.

Mariana N Castro (MN)

Grupo de Investigación en Neurociencias Aplicadas a las Alteraciones de la Conducta (INAAC), Fleni-Consejo Nacional de Investigaciones Científicas y Técnicas Neurosciences Institute (INEU), Ciudad Autónoma de Buenos Aires C1428, Argentina.
Department of Psychiatry and Mental Health, School of Medicine, University of Buenos Aires, Ciudad Autónoma de Buenos Aires C1114AAD, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires C1033AAJ, Argentina.

Tiffany Chaim-Avancini (T)

Laboratory of Psychiatric Neuroimaging (LIM-21), Departamento e Instituto de Psiquiatria, Hospital das Clinicas, Faculdade de Medicina Universidade de São Paulo (HCFMUSP), Faculdade de Medicina Universidade de São Paulo, São Paulo SP 05403-903, Brazil.

Albert Compte (A)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona 08036, Spain.

Monise Costanzi (M)

Laboratory of Molecular Psychiatry, Centro de Pesquisa Clínica, Hospital de Clínicas de Porto Alegre, Porto Alegre RS 90035-007, Brazil.

Leticia Czepielewski (L)

Laboratory of Molecular Psychiatry, Centro de Pesquisa Clínica, Hospital de Clínicas de Porto Alegre, Porto Alegre RS 90035-007, Brazil.
Programa de Pós-Graduação em Psicologia, Instituto Psicologia, Universidade Federal do Rio Grande do Sul, Porto Alegre RS 90040-060, Brazil.

Paola Dazzan (P)

Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, United Kingdom.

Camilo de la Fuente-Sandoval (C)

Laboratory of Experimental Psychiatry, Direction of Research, Instituto Nacional de Neurología y Neurocirugía, Mexico City 14269, Mexico.

Marta Di Forti (M)

Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, United Kingdom.
National Institute for Health Research (NIHR), Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, King's College London, London SE5 8AZ, United Kingdom.

Covadonga M Díaz-Caneja (CM)

Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Centro de Investigación Biomédica en Red Salud Mental (CIBERSAM), School of Medicine, Universidad Complutense, Madrid 28009, Spain.

Ana María Díaz-Zuluaga (A)

Department of Psychiatry, Faculty of Medicine, University of Antioquia, Medellín 050011, Colombia.
Center for Neurobehavioral Genetics, Jane and Terry Semel Institute for Neuroscience and Human Behavior Los Angeles, University of California Los Angeles (UCLA), Los Angeles, CA 90024.

Stefan Du Plessis (S)

Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7602, South Africa.
South African Medical Research Council (SA MRC), Genomics of Brain Disorders Unit, Cape Town 7505, South Africa.

Fabio L S Duran (FLS)

Laboratory of Psychiatric Neuroimaging (LIM-21), Departamento e Instituto de Psiquiatria, Hospital das Clinicas, Faculdade de Medicina Universidade de São Paulo (HCFMUSP), Faculdade de Medicina Universidade de São Paulo, São Paulo SP 05403-903, Brazil.

Sol Fittipaldi (S)

Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago 7941169, Chile.
Cognitive Neuroscience Center (CNC), Universidad de San Andres, Victoria, Ciudad Autónoma de Buenos Aires B1644BID, Argentina.
Global Brain Health Institute (GBHI), Trinity College Dublin (TCD), Dublin DO2 PN40, Ireland.
Global Brain Health Institute (GBHI), University of California San Francisco (UCSF), San Francisco, CA 94158.

Alex Fornito (A)

The Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, VIC 3168, Australia.
Monash Biomedical Imaging, Monash University, Melbourne, VIC 3168, Australia.

Nelson B Freimer (NB)

Center for Neurobehavioral Genetics, Jane and Terry Semel Institute for Neuroscience and Human Behavior Los Angeles, University of California Los Angeles (UCLA), Los Angeles, CA 90024.

Ary Gadelha (A)

Interdisciplinary Laboratory in Clinical Neuroscience (LiNC), Department of Psychiatry, Federal University of São Paulo, São Paulo 04039-032, Brazil.

Clarissa S Gama (CS)

Laboratory of Molecular Psychiatry, Centro de Pesquisa Clínica, Hospital de Clínicas de Porto Alegre, Porto Alegre RS 90035-007, Brazil.
Department of Psychiatry, Universidade Federal do Rio Grande do Sul (UFRGS), Hospital de Clinicas de Porto Alegre, Porto Alegre, RS 90035903, Brazil.

Ranjini Garani (R)

Integrated Program in Neuroscience, McGill University, Montreal, Quebec H3A 1A12B4 Canada.

Clemente Garcia-Rizo (C)

Barcelona Clinic Schizophrenia Unit, Hospital Clínic de Barcelona, Departament de Medicina, Institut de Neurociències (UBNeuro), Universitat de Barcelona (UB), Institut d'Investigacions Biomèdiques, August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Barcelona 08036, Spain.

Cecilia Gonzalez Campo (C)

Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires C1033AAJ, Argentina.
Cognitive Neuroscience Center (CNC), Universidad de San Andres, Victoria, Ciudad Autónoma de Buenos Aires B1644BID, Argentina.

Alfonso Gonzalez-Valderrama (A)

Early Intervention Program, Instituto Psiquiátrico Dr. J. Horwitz Barak, Santiago 8431621, Chile.
School of Medicine, Universidad Finis Terrae, Santiago 7501015, Chile.

Salvador Guinjoan (S)

Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires C1033AAJ, Argentina.
Laureate Institute for Brain Research, Tulsa, OK 74136.

Bharath Holla (B)

Department of Integrative Medicine, NIMHANS, Bengaluru, Karnataka 560029, India.
Accelerator Program for Discovery in Brain disorders using Stem cells, Department of Psychiatry, NIMHANS, Bengaluru, Karnataka 560029, India.

Agustín Ibañez (A)

Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago 7941169, Chile.
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires C1033AAJ, Argentina.
Cognitive Neuroscience Center (CNC), Universidad de San Andres, Victoria, Ciudad Autónoma de Buenos Aires B1644BID, Argentina.
Global Brain Health Institute (GBHI), Trinity College Dublin (TCD), Dublin DO2 PN40, Ireland.
Global Brain Health Institute (GBHI), University of California San Francisco (UCSF), San Francisco, CA 94158.

Daniza Ivanovic (D)

Laboratorio de Neurociencia Social y Neuromodulación, Centro de Investigación en Complejidad Social (neuroCICS), Facultad de Gobierno, Universidad del Desarrollo, Santiago 7610658, Chile.

Andrea Jackowski (A)

Department of Psychiatry, Universidade Federal de São Paulo, São Paulo 04038-000, Brazil.
Department of Education, Information and Communications Technology (ICT) and Learning, Østfold University College, Halden 1757, Norway.

Pablo Leon-Ortiz (P)

Laboratory of Experimental Psychiatry, Direction of Research, Instituto Nacional de Neurología y Neurocirugía, Mexico City 14269, Mexico.

Christine Lochner (C)

South African Medical Research Council (SA MRC) Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry, Stellenbosch University, Stellenbosch 7505, South Africa.

Carlos López-Jaramillo (C)

Department of Psychiatry, Faculty of Medicine, University of Antioquia, Medellín 050011, Colombia.

Hilmar Luckhoff (H)

Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7602, South Africa.

Raffael Massuda (R)

Department of Psychiatry, Universidade Federal do Paraná (UFPR), Curitiba PR 80060-000, Brazil.

Philip McGuire (P)

Department of Psychiatry, University of Oxford, Oxford OX3 7JX, United Kingdom.
Wellcome Centre for Integrative Neuroimaging (WIN), University of Oxford, Oxford OX3 9DU, United Kingdom.
NIHR Oxford Health Biomedical Research Centre, Oxford OX3 7JX, United Kingdom.
Oxford Health National Health Service (NHS), Foundation Trust, Oxford OX4 4XN, United Kingdom.

Jun Miyata (J)

Department of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.

Romina Mizrahi (R)

Integrated Program in Neuroscience, McGill University, Montreal, Quebec H3A 1A12B4 Canada.
Clinical and Translational Sciences Lab, McGill University, Douglas Mental Health University Institute, Montreal, QC H4A 1R3, Canada.
Department of Psychiatry, McGill University, Montreal, QC H3A 1A1, Canada.

Robin Murray (R)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, United Kingdom.

Aysegul Ozerdem (A)

Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota MN 55905.

Pedro M Pan (PM)

Interdisciplinary Laboratory in Clinical Neuroscience (LiNC), Department of Psychiatry, Federal University of São Paulo, São Paulo 04039-032, Brazil.
National Institute of Developmental Psychiatry for Children and Adolescents, São Paulo 04038-000, Brazil.

Mara Parellada (M)

Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Centro de Investigación Biomédica en Red Salud Mental (CIBERSAM), School of Medicine, Universidad Complutense, Madrid 28009, Spain.

Lebogan Phahladira (L)

Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7602, South Africa.

Juan P Ramirez-Mahaluf (JP)

Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8330077, Chile.

Ramiro Reckziegel (R)

Laboratory of Molecular Psychiatry, Centro de Pesquisa Clínica, Hospital de Clínicas de Porto Alegre, Porto Alegre RS 90035-007, Brazil.

Tiago Reis Marques (T)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, United Kingdom.

Francisco Reyes-Madrigal (F)

Laboratory of Experimental Psychiatry, Direction of Research, Instituto Nacional de Neurología y Neurocirugía, Mexico City 14269, Mexico.

Annerine Roos (A)

South African Medical Research Council (SA MRC) Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town 7925, South Africa.

Pedro Rosa (P)

Laboratory of Psychiatric Neuroimaging (LIM-21), Departamento e Instituto de Psiquiatria, Hospital das Clinicas, Faculdade de Medicina Universidade de São Paulo (HCFMUSP), Faculdade de Medicina Universidade de São Paulo, São Paulo SP 05403-903, Brazil.

Giovanni Salum (G)

Department of Psychiatry, Universidade Federal do Rio Grande do Sul (UFRGS), Hospital de Clinicas de Porto Alegre, Porto Alegre, RS 90035903, Brazil.
National Institute of Developmental Psychiatry for Children and Adolescents, São Paulo 04038-000, Brazil.

Freda Scheffler (F)

South African Medical Research Council (SA MRC) Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town 7925, South Africa.

Gunter Schumann (G)

Centre for Population Neuroscience and Stratified Medicine (PONS), Institute for Science and Technology for Brain-inspired Intelligence, Fudan University, Shanghai 200433, China.
PONS-Centre, Charité Mental Health, Dept of Psychiatry and Psychotherapy, Charité Campus Mitte, Berlin 10117, Germany.

Mauricio Serpa (M)

Departamento e Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-903, Brazil.

Dan J Stein (DJ)

South African Medical Research Council (SA MRC) Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town 7925, South Africa.

Angeles Tepper (A)

Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8330077, Chile.

Jeggan Tiego (J)

The Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, VIC 3168, Australia.
Monash Biomedical Imaging, Monash University, Melbourne, VIC 3168, Australia.

Tsukasa Ueno (T)

Department of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
Integrated Clinical Education Center, Kyoto University Hospital, Kyoto 606-8397, Japan.

Juan Undurraga (J)

Early Intervention Program, Instituto Psiquiátrico Dr. J. Horwitz Barak, Santiago 8431621, Chile.
Department of Neurology and Psychiatry, Faculty of Medicine, Clínica Alemana Universidad del Desarrollo Vitacura, Santiago 7650568, Chile.

Eduardo A Undurraga (EA)

Escuela de Gobierno, Pontificia Universidad Católica de Chile, Santiago 7820436, Chile.
Research Center for Integrated Disaster Risk Management (CIGIDEN), Santiago 7820436, Chile.
Canadian Institute for Advanced Research (CIFAR), Azrieli Global Scholars Program, CIFAR, Toronto, ON M5G 1M1, Canada.

Pedro Valdes-Sosa (P)

The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu 610054, China.
Centro de Neurociencias de Cuba, La Habana 11600, Cuba.

Isabel Valli (I)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona 08036, Spain.
Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, United Kingdom.

Mirta Villarreal (M)

Grupo de Investigación en Neurociencias Aplicadas a las Alteraciones de la Conducta (INAAC), Fleni-Consejo Nacional de Investigaciones Científicas y Técnicas Neurosciences Institute (INEU), Ciudad Autónoma de Buenos Aires C1428, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires C1033AAJ, Argentina.
Department of Physics, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires C1428EGA, Argentina.

Toby T Winton-Brown (TT)

Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia.
Department of Psychiatry, Alfred Health, Melbourne, VIC 3004, Australia.

Nefize Yalin (N)

Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, United Kingdom.
South London and Maudsley National Health Service (NHS), Foundation Trust, London SE5 8AZ, United Kingdom.

Francisco Zamorano (F)

Unidad de Imágenes Cuantitativas Avanzadas, Departamento de Imágenes, Clínica Alemana de Santiago, Universidad del Desarrollo, Santiago 7650568, Chile.
Facultad de Ciencias para el Cuidado de la Salud, Universidad San Sebastián, Santiago 7510602, Chile.

Marcus V Zanetti (MV)

Laboratory of Psychiatric Neuroimaging (LIM-21), Departamento e Instituto de Psiquiatria, Hospital das Clinicas, Faculdade de Medicina Universidade de São Paulo (HCFMUSP), Faculdade de Medicina Universidade de São Paulo, São Paulo SP 05403-903, Brazil.
Hospital Sírio-Libanês, São Paulo 01308-050, Brazil.

Anderson M Winkler (AM)

Department of Human Genetics, University of Texas Rio Grande Valley, Brownsville, Texas TX 78520.

Daniel S Pine (DS)

Section on Development and Affective Neuroscience (SDAN), Emotion and Development Branch (E & D), National Institute of Mental Health, National Institutes of Health, Bethesda MD 20894.

Sara Evans-Lacko (S)

Care Policy and Evaluation Centre, School of Economics and Political Science, London WC2A 2AE, United Kingdom.

Nicolas A Crossley (NA)

Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8330077, Chile.
Department of Psychiatry, University of Oxford, Oxford OX3 7JX, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH